SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By Board Of Greenway Medical Technologies, Inc. In Connection With Sale Of Company To Vista Equity Partners
Levi & Korsinsky is investigating the Board of Directors of Greenway Medical Technologies, Inc. (“Greenway Medical” or the “Company”) (NYSE:GWAY) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Vista Equity Partners. Greenway Medical will merge with Vista Equity Partners’ subsidiary, Vitera Healthcare Solutions.
Click here to learn more about the investigation http://zlk.9nl.com/greenway-medical-technologies-gway/, or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Greenway Medical shareholders will receive $20.35 for each share of Greenway Medical stock they own. Certain Greenway insiders, including the Board of Directors and certain executive officers owning a collective 50.9% of Greenway’s outstanding shares, have already agreed to tender their shares. The investigation concerns whether the Greenway Medical Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether the Board of Directors is acting in shareholders’ best interests.
If you own Greenway Medical common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/greenway-medical-technologies-gway/.Levi & Korsinsky is a national firm with offices in New York, New Jersey and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts